The Type 1 Diabetes Defense Foundation is a nonpartisan Oregon-based 501(c)(3) nonprofit dedicated to advancing equal rights and opportunities for Americans with type 1 and other forms of insulin dependent diabetes. T1DF depends on individual donations and accepts no industry funding.

“Your willingness to step forward initiated important developments for the rights of students with diabetes in our community.”
— Assistant U.S. Attorney Kayla Stahman, Health Care Fraud Coordinator, Western District of Washington

T1DF cares about the significant social impact of living with a condition that requires patients to make constant dosing decisions with drugs that, without careful management and monitoring, can kill them.

We believe in a world where people who use insulin have full access to education, employment, and health care.

We work through impact litigation, lobbying, and campaigns to raise public awareness about discrimination that affects people with T1D, whether discrimination means direct limits on access or demands to waive legal right to accommodation as a condition of access.

Civil Rights Program

Our current civil rights program focus is on K-12 school access and accommodation in Washington State and Oregon, including compliance with Section 504 and access to emergency glucagon in case of life-threatening severe hypoglycemia.

Consumer Rights Program

T1DF’s current consumer rights program challenges the overpricing of analog insulins, emergency glucagon kits, and blood glucose test strips. 

 
 

Pending Cases

INSULIN OVERPRICING

Home page - insulin.jpg

Boss, et al. v. CVS Health Corporation et al.
United States District Court, District of New Jersey, Case No. 3:17-cv-01823-BRM-LHG. In November 2018, this case was unconsolidated from In re Insulin Pricing Litigation, Case No. 3:17-cv-00699-BRM-LHG.

TEST STRIPS OVERPRICING

test-strips.png

Prescott, et al. v. CVS Health Corporation, et al.
United States District Court, Western District of Washington, Case No. 2:17-cv-00803-RAJ. This case has been transferred to the United States District Court, District of New Jersey, Case No. 3:2017-cv-13066-BRM-LHG.

GLUCAGON KIT OVERPRICING 

glucagon.png

Bewley, et al. v. CVS Health Corporation, et al.
United States District Court, Western District of Washington, Case No. 2:17-cv-00802-RAJ. This case has been transferred to the United States District Court, District of New Jersey, Case No. 3:2017-cv-12031-BRM-LHG.